RESUMO
INTRODUCTION: Substance use disorder consists of the presence of cognitive, behavioral, and physiological symptoms, indicating continuous use of one or more substances by the individual. The literature points to the existence of a relationship between impulsive behavior, in which individuals tend to act thoughtlessly and with a lower level of planning, and consumption of substances including cannabis. OBJECTIVES: To examine the presence and severity of impulsivity in individuals with cannabis use disorder and investigate associations between sociodemographic and clinical characteristics and impulsivity. METHOD: Participants completed a sociodemographic data sheet and the Barratt Impulsiveness Scale (BIS-11). A total of 122 subjects with a diagnosis of cannabis use disorder participated, with a mean age of 34.46 years (standard deviation = 9.62). RESULTS: The prevalence of high levels of impulsivity in the sample ranged from 30 to 33%; the BIS-11 total score was significantly associated with cohabitation and alcohol use. The BIS-11 scores for motor impulsivity and attentional impulsivity were also associated with consumption of alcohol. No associations were found between impulsivity and the variables age, education, use of tobacco, or use of cocaine/crack. CONCLUSION: This study contributes to understanding of substance dependence, especially cannabis. It found presence of impulsive behavior among individuals with cannabis use disorder, which is corroborated by reports in the literature.
Assuntos
Abuso de Maconha , Transtornos Relacionados ao Uso de Substâncias , Adulto , Humanos , Comportamento Impulsivo , Abuso de Maconha/complicações , Abuso de Maconha/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/psicologiaRESUMO
Attention allows us to select relevant information from the background. Although several studies have described that cannabis use induces deleterious effects on attention, it remains unclear if cannabis dependence affects the attention network systems differently. OBJECTIVES: To evaluate whether customary consumption of cannabis or cannabis dependence impacts the alerting, orienting, and executive control systems in young adults; to find out whether it is related to tobacco or alcohol dependence and if cannabis use characteristics are associated with the attention network systems. METHOD: One-hundred and fifty-four healthy adults and 102 cannabis users performed the Attention Network Test (ANT) to evaluate the alerting, orienting, and executive control systems. RESULTS: Cannabis use enhanced the alerting system but decreased the orienting system. Moreover, those effects seem to be associated with cannabis dependence. Out of all the cannabis-using variables, only the age of onset of cannabis use significantly predicted the efficiency of the orienting and executive control systems. CONCLUSION: Cannabis dependence favors tonic alertness but reduces selective attention ability; earlier use of cannabis worsens the efficiency of selective attention and resolution of conflicts.
Assuntos
Alcoolismo , Abuso de Maconha , Função Executiva , Humanos , Abuso de Maconha/complicações , Abuso de Maconha/epidemiologia , Orientação , Tempo de Reação , Adulto JovemRESUMO
Introducción: Durante los últimos sesenta años se ha construido evidencia sobre los efectos adversos relacionados con el consumo crónico de cannabis. Los problemas de memoria y concentración, el riesgo de esquizofrenia en sujetos predispuestos y el síndrome amotivacional han sido referenciados. Con los primeros al parecer no hay muchas dudas, pero en relación con el último, existe controversia. Objetivo: revisar la evidencia científica existente sobre el síndrome amotivacional. Material y Métodos: La revisión se realizó mediante una búsqueda en bases de datos académicas, se tomaron en cuenta las publicaciones que estuvieran relacionadas con trastornos mentales relacionados con el consumo crónico de marihuana en los que se hacía referencia al síndrome amotivacional que cumplieran con criterios de calidad de los artículos apegados a estándares internacionales. Desarrollo: Se incluyó un total de 31 artículos, de los cuales 16 incluían la definición de síndrome amotivacional. Una vez integradas todas las fuentes, se determinó organizar la evidencia encontrada en 15 factores: apatía; desinterés; pasividad; indiferencia; demora en la realización de tareas; pereza; presentismo; desgano para actividades prolongadas que requieran atención o tenacidad; abandono del cuidado personal; desinterés sexual; disminución de los reflejos; autoeficacia disminuida; deterioro de las habilidades comunicativas; retraimiento social y afecto no alterado. Conclusiones: A partir de los hallazgos, se sugiere que el síndrome amotivacional es una constelación de síntomas y/o signos relacionados, lo que podría constituir una morbilidad propia del consumo crónico de cannabis, se espera que en el futuro se desarrollen investigaciones que prueben o rechacen su existencia(AU)
Introduction: Over the past sixty years, evidence for the adverse effects of chronic cannabis use has been demonstrated. Memory and concentration problems, the risk of schizophrenia in predisposed subjects, and amotivational syndrome have been referenced. There is not much doubt in relation to the first effect mentioned, but there is controversy around the last. Objective: To review the existing scientific evidence for the amotivational syndrome. Material and Methods: The review was conducted through academic database searching. The publications related to mental disorders associated with the chronic marijuana use, which referred to amotivational syndrome that fulfilled the criteria for articles attached to international standards, were taken into account. Results: A total of 31 articles were included. Of them, 16 presented the definition of amotivational syndrome. Once all the sources were integrated, the evidence found in 15 factors was organized. These factors included: apathy; disinterest; passivity; indifference; delay to perform tasks; sloth; presentism; reluctance to do prolonged activities that require attention or tenacity; abandonment of personal care; sexual disinterest; decreased reflexes; decreased self-efficacy; impairment in communication skills; social withdrawal, and unaltered affection. Conclusions: Based on these findings, we suggest that the amotivational syndrome is a constellation of symptoms and / or related signs which could constitute a typical morbidity caused by chronic cannabis use, so we expect that future research will be developed to demonstrate or discard their existence(AU)
Assuntos
Humanos , Pesquisa , Apatia/efeitos dos fármacos , Presenteísmo/métodos , Uso da Maconha/efeitos adversos , Procrastinação/efeitos dos fármacos , Transtornos Mentais , Abuso de Maconha/complicaçõesRESUMO
ABSTRACT Objective. To report demographic and substance use characteristics and risk of road traffic injury (RTI) from alcohol use, cannabis use, and combined use in a sample of emergency department patients from two countries in Latin America and the Caribbean. Methods. A cross-sectional study in which patients 18 years and older admitted within six hours of suffering an RTI to one emergency department in Santa Domingo, Dominican Republic (n = 501) and in Lima, Peru (n = 431) were interviewed. Case-crossover analysis, based on self-reported use prior to the RTI, was used to analyze risk from alcohol, cannabis, and co-use. Results. Overall, 15.3% reported alcohol use prior to the event and 2.5% cannabis use. Drivers using alcohol only were over twice as likely to have an RTI (OR = 2.46, p < 0.001), and nearly eight times more likely if using both alcohol and cannabis (OR = 6.89, p < 0.01), but risk was not elevated for cannabis alone. Significant differences were not found for passengers or pedestrians. Conclusions. Risk of RTI for drivers in these two samples is significantly elevated from alcohol use, and more so for co-use with cannabis. Differences between the two countries underscore the need for similar data from the region to determine risk of RTI from substance use, including risk for passengers and pedestrians. Data suggest that alcohol contributes significantly to the burden of RTI, which calls for more stringent enforcement of alcohol control policy related to drink driving in the region.
RESUMEN Objetivo. Presentar las características demográficas y de consumo de sustancias psicoactivas y el riesgo de traumatismos causados por el tránsito debidos al consumo de alcohol, cannabis y su consumo combinado en una muestra de pacientes del departamento de urgencias de dos países de América Latina y el Caribe. Métodos. Se realizó un estudio transversal en que se entrevistaron pacientes de 18 años o más ingresados en las siguientes seis horas de haber recibido traumatismos causados por el tránsito en un departamento de urgencias en Lima (Perú) (n = 431) y en Santo Domingo (República Dominicana) (n = 501). Se empleó el análisis de cruce de casos, basado en el consumo autoinformado con anterioridad a los traumatismos causados por el tránsito, para evaluar el riesgo por consumo de alcohol, cannabis y consumo combinado. Resultados. En términos generales, 15,3% notificó consumo de alcohol con anterioridad al evento y 2,5%, consumo de cannabis. Los conductores que consumieron alcohol únicamente tuvieron más del doble de probabilidades de sufrir traumatismos causados por el tránsito (OR = 2,46, p < 0,001) y casi ocho veces más probabilidades si consumieron tanto alcohol como cannabis (OR = 6,89, p < 0,01), si bien el riesgo no fue tan elevado para el consumo único de cannabis. No se encontraron diferencias significativas en pasajeros o peatones. Conclusiones. El riesgo de sufrir traumatismos causados por el tránsito para los conductores en estas dos muestras es significativamente más elevado por el consumo de alcohol y más aún por el consumo combinado con cannabis. Las diferencias entre ambos países ponen de manifiesto la necesidad de obtener datos similares sobre la región para determinar el riesgo de sufrir traumatismos causados por el tránsito debidos al consumo de sustancias psicoactivas, así como el riesgo para pasajeros y peatones. Los datos indican que el alcohol agrava significativamente la carga de los traumatismos causados por el tránsito, lo que exige un cumplimiento más estricto de las políticas de control del alcohol relacionadas con la conducción bajo los efectos del alcohol en la región.
RESUMO Objetivo. Descrever as características demográficas e uso de substâncias químicas e o risco de lesões por acidentes de trânsito associados ao consumo de álcool, uso de cannabis (maconha) e uso combinado de álcool e cannabis em uma amostra de pacientes que deram entrada no setor de emergência em dois países da América Latina e no Caribe. Métodos. Estudo transversal em que foram entrevistados pacientes maiores de 18 anos que deram entrada no setor de emergência no espaço de seis horas após sofrerem lesões por acidentes de trânsito em Santo Domingo, na República Dominicana (n = 501), e em Lima, Peru (n = 431). Foi realizada uma análise cruzada de casos com dados obtidos do autorrelato do uso de substâncias químicas anterior ao acidente de trânsito para avaliar o risco associado ao consumo de álcool, uso de cannabis e uso combinado. Resultados. Dos pacientes entrevistados, 15,3% relataram consumo de álcool e 2,5% referiram uso de cannabis antes do acidente. Os condutores que fizeram uso de álcool tiveram uma chance duas vezes maior de ter lesões por acidente de trânsito (OR = 2,46, p < 0,001) e uma chance de cerca de oito vezes maior com o uso combinado de álcool e cannabis (OR = 6,89, p < 0,01). Porém, o risco não foi elevado com o uso somente de cannabis. Não foram observadas diferenças significativas no risco para passageiros ou pedestres. Conclusões. Verificou-se que o risco de lesões por acidentes de trânsito para os condutores nas duas amostras estudadas foi significativamente elevado com o consumo de álcool e foi ainda maior com o uso combinado de álcool e cannabis. As diferenças entre os dois países reforçam a necessidade de dados semelhantes da Região para determinar o risco de lesões por acidentes de trânsito com o uso de substâncias químicas, inclusive para determinar o risco para passageiros e pedestres. Os dados indicam que o álcool contribui significativamente à carga de lesões por acidentes de trânsito requerendo o cumprimento mais rigoroso da política de controle do consumo de álcool associado à condução de veículos na Região.
Assuntos
Humanos , Masculino , Feminino , Adulto , Traumatismo Múltiplo/epidemiologia , Acidentes de Trânsito/estatística & dados numéricos , Abuso de Maconha/complicações , Transtornos Relacionados ao Uso de Álcool/epidemiologia , Peru/epidemiologia , Fatores Socioeconômicos , Abuso de Maconha/epidemiologia , Estudos Transversais , Medição de Risco , República Dominicana/epidemiologiaRESUMO
OBJECTIVE: We examined the frequency of diabetic ketoacidosis (DKA) in cannabis users compared with nonusers in the T1D Exchange clinic registry (T1DX). RESEARCH DESIGN AND METHODS: The association between cannabis use by total substance score for cannabis (TSC) and DKA in the past 12 months was examined using a logistic regression model adjusted for potential confounders among adults in the T1DX. RESULTS: Of 932 adults with type 1 diabetes, 61 had a TSC >4, which classified them as moderate cannabis users. Adjusting for sex, age at study visit, and HbA1c, cannabis use was associated with a twofold increase in risk for DKA among adults with type 1 diabetes (odds ratio 2.5 [95% CI 1.0-5.9]). CONCLUSIONS: Cannabis use was associated with an increased risk for DKA among adults in the T1DX. Providers should inform their patients of the potential risk of DKA with cannabis use.
Assuntos
Diabetes Mellitus Tipo 1/epidemiologia , Cetoacidose Diabética/epidemiologia , Abuso de Maconha/epidemiologia , Fumar Maconha/epidemiologia , Adolescente , Adulto , Cannabis/efeitos adversos , Diabetes Mellitus Tipo 1/complicações , Cetoacidose Diabética/etiologia , Feminino , Humanos , Masculino , Abuso de Maconha/complicações , Fumar Maconha/efeitos adversos , Sistema de Registros , Fatores de Risco , Adulto JovemRESUMO
Mortality among individuals co-infected with HIV and hepatitis C virus (HCV) is relatively high. We evaluated the association between psychoactive substance use and both HCV and non-HCV mortality in HIV/HCV co-infected patients in France, using Fine and Gray's competing-risk model adjusted for socio-demographic, clinical predictors and confounding factors, while accounting for competing causes of death. Over a 5-year median follow-up period, 77 deaths occurred among 1028 patients. Regular/daily cannabis use, elevated coffee intake, and not currently smoking were independently associated with reduced HCV-mortality (adjusted sub-hazard ratio [95% CI] 0.28 [0.10-0.83], 0.38 [0.15-0.95], and 0.28 [0.10-0.79], respectively). Obesity and severe thinness were associated with increased HCV-mortality (2.44 [1.00-5.93] and 7.25 [2.22-23.6] versus normal weight, respectively). Regular binge drinking was associated with increased non-HCV-mortality (2.19 [1.10-4.37]). Further research is needed to understand the causal mechanisms involved. People living with HIV/HCV co-infection should be referred for tobacco, alcohol and weight control interventions and potential benefits of cannabis-based therapies investigated.